Now I have a comprehensive understanding of the paper and all the reviewer claims. Let me write the consolidated final review.

## Summary

This paper presents a large-scale benchmark comparing 13 deep learning models (spatial/FC-based and sequential/BOLD-based) across 34,887 samples from six public fMRI datasets (HCP-Task, HCP-WM, ADNI, OASIS, PPMI, ABIDE). The goal is to establish empirical guidelines for model selection based on fMRI application type — recommending sequential models for task-evoked fMRI, spatial models for neurodegenerative disease classification, and spatial-temporal hybrids for neuropsychiatric disorders. The paper also includes a qualitative post-hoc interpretability analysis of brain region importance.

## Strengths

- **Large-scale, multi-dataset benchmark at unprecedented scope**: The paper evaluates 13 models on 34,887 samples across six datasets spanning both task-evoked and resting-state fMRI, covering cognitive tasks, neurodegenerative diseases (AD, PD), and neuropsychiatric disorders (autism). This is the broadest comparison in terms of data scope among current benchmarks and includes recent architectures (Mamba, SPDNet, GNN-AK, MLP-Mixer) not covered in prior works (Said et al., Xu et al.).

- **Test-retest experimental design for replicability**: The "Separated Scan 1 & Scan 2" setting on HCP data — training on one scan session and testing on a separate retest session — is a thoughtful methodological choice that goes beyond typical benchmarks by evaluating whether models generalize across different scan sessions of the same task. This is a genuine strength that most benchmarks lack.

- **Connecting model performance to neuroscience domain knowledge**: The paper attempts to link empirical results to biological mechanisms (e.g., stable network topology during tasks vs. disconnection syndrome in ND, spatial-temporal disruption in autism), offering testable explanations for why different model families excel in different settings. This provides value beyond a raw performance table.

## Weaknesses

### Fatal
None.

### Major

1. **Missing variance estimates on the central task-fMRI results (Table 1 top)** : The HCP-Task and HCP-WM results in Table 1 are reported as point estimates without standard deviations, error bars, or any measure of variance across random seeds or cross-validation folds. The disease-dataset results (ADNI, OASIS, PPMI, ABIDE) include ±std, making the omission on the HCP results conspicuous. Without these, it is impossible to assess whether the observed performance gaps (e.g., the ~30% gap in HCP-WM separated setting) are stable or driven by a single favorable initialization. This directly weakens the paper's strongest quantitative claims (sequential advantage on task-fMRI, t-statistics of -13.3 with p<10⁻⁴). The group-level t-tests aggregate across models but do not capture run-to-run variability for each model.

2. **Architecture and input representation are fundamentally confounded, limiting the biological conclusions**: The paper defines "spatial models" as those taking FC matrices as input and "sequential models" as those taking BOLD time series. The core biological interpretations (Remarks 1.1, 2.1, 3.1) attribute performance differences to intrinsic properties of model architectures (GNN vs. RNN/Transformer), but the experimental design never disentangles architecture from input modality. The observed differences could equally reflect which *input representation* (FC topology vs. raw BOLD dynamics) carries more label-relevant signal in each setting. The paper should explicitly acknowledge this confound and caveat the biological claims accordingly. A clean decoupling experiment — e.g., feeding FC features to sequential models or BOLD features to spatial models — would strengthen the conclusions significantly.

3. **Group-level comparisons are driven by the strongest models and overstate systematic advantages**: The paper aggregates all spatial models versus all sequential models for group t-tests, but within each group, performance variance is enormous (e.g., GNN-AK at 72.19% vs. SPDNet at 96.23% on HCP-Task Mixed — both "spatial"). The group-level advantage is primarily driven by the best-performing model in each category rather than reflecting a systematic property of all models in that class. The claim that "spatial models are more effective" for ND is particularly weak: on ADNI, the best spatial (MLP 80.4%) barely edges the best sequential (Transformer 79.2%) — a 1.2% gap well within error bars — and the t-test is non-significant (p=0.37). The paper hedges in some places (acknowledging non-significance) but then contradicts this in Remarks 2.1 and 2.2 by asserting spatial models are "more effective."

4. **H2 referenced in Discussion but never introduced in Section 5**: The paper lists H1, H3, H4 at the start of Section 5 (lines 106-109) but omits H2 entirely. Yet the Discussion answers "(H2) is 'YES'" (line 294). While the content of H2 can be inferred, this is a clear structural inconsistency in a paper that claims to provide principled guidelines.

### Minor

1. **The explainability analysis is qualitative and does not support any rigorous conclusion**: The analysis identifies "top 40 brain regions" via logistic regression weights from model-extracted features, but never specifies how features are extracted from each model before regression fitting. The brain maps (Figs. 3, 4) are hand-annotated with subjective labels, with no quantitative comparison to established brain atlases (e.g., Neurosynth meta-analytic maps), no statistical test of region overlap, and no random baseline. The paper's own assessment — "the findings are not yet converging" — concedes the analysis cannot support any conclusion. This section is better framed as an exploratory illustration rather than a substantive evaluation of interpretability.

2. **Alternative explanations for poor spatial model performance on HCP-WM not discussed**: The paper attributes sequential models' large advantage on HCP-WM (short 39-timepoint scans) to superior capture of temporal dynamics. However, FC matrices computed from only 39 time points are notoriously noisy; the spatial models' near-chance performance (GCN 26.83%, 8-class) could simply reflect poor FC estimates rather than any architectural deficiency. This alternative explanation is not considered.

3. **Preprocessing detail insufficient for reproducibility**: "Standardize the input BOLD signal with varying time length to uniform dimensions" (line 115) is underspecified — it is unclear whether this involves zero-padding, truncation, interpolation, or some other approach. While detailed supplement content is stripped by the parser, the main text should at least reference the method used.

4. **SPDNet's hybrid nature challenges the binary taxonomy**: SPDNet is categorized as a "spatial" model (FC matrix input) but explicitly uses a spatial-temporal framework (manifold learning + RNN for temporal dynamics). This is acknowledged in the discussion of ABIDE results (lines 242-251) but the binary spatial/sequential framing elsewhere treats it as a standard spatial model, which is inconsistent.

### Trivial
- The abstract states "34,887 data samples from six public databases" but the table sums to 34,887 (14,860+17,296+250+1,247+209+1,025). The arithmetic checks out. No actual issues.

## Nice-to-Haves
- Adding chance-level baselines (majority-class, logistic regression on flattened FC/mean BOLD) would help contextualize the deep models' value.
- Confusion matrices for HCP-WM (8-class) would clarify whether spatial model errors are structured (e.g., confusing 0bk with 2bk conditions) or random.
- Reporting model sizes, training times, or tuning budgets would address concerns about whether performance gaps reflect modeling power vs. optimization difficulty.
- Quantitative interpretability evaluation (e.g., Dice overlap with Neurosynth maps) would turn the subjective brain maps into a meaningful comparison.

## Removed Points

- **Criticism about multiple comparison correction across datasets**: The t-tests are conducted on independent datasets with separate research questions (task-fMRI vs. ND vs. autism). Applying correction across independent experiments is not standard practice. This point is removed.

- **Criticism that "the paper should note potential confounding factors (demographics, class balance)"**: The paper's scope is model performance comparison, not epidemiological analysis. Demographics are secondary for this purpose, and the datasets are well-established public benchmarks. This is scope creep.

- **Criticism about "no confidence intervals for large-scale benchmarks"**: The disease datasets already include ±std. The HCP results missing error bars is already flagged as a Major weakness. This is redundant.

- **Criticism that "the aggregated spatial group comparison lumps together models with wildly different performance"**: This is already covered in Major weakness #3 with more precision.

- **Strength Finder's claim about "statistically grounded conclusions"**: This conflicts with the verified weakness about missing error bars on HCP results. The weakness wins, so this strength claim is moved here.

- **Strength Finder's generic strength about "inclusive model selection covering recent advances"**: This is a standard feature of any benchmark and is not a distinctive strength. Tables clearly show which models are included.

## Novel Insights

None beyond the paper's own contributions. The reviews do not surface a perspective that the paper itself does not already touch on or that cannot be derived from reading its tables.

## Suggestions

1. **Add error bars/standard deviations to all HCP-Task and HCP-WM entries in Table 1** by running each model over multiple random seeds (at least 5). This is the single most impactful fix. Without it, the paper's strongest quantitative claims rest on unverifiable point estimates.

2. **Explicitly acknowledge the architecture-input confound** (Weakness #2 above) in both the experimental setup and the conclusions. Reframe the contribution as comparing *pipelines* (input representation + model architecture) rather than model architectures alone, or add at least one control experiment (e.g., training a Transformer/RNN on FC-derived features or a GNN on time-series node features).

3. **Tone down overclaims in the disease analysis**: For ADNI (1.2% gap within error bars, p=0.37), the conclusion should be "spatial and sequential models perform comparably" rather than "spatial models are more effective." The selective advantage claim is better supported on task-fMRI (HCP-WM) and autism (SPDNet).

4. **Fix the H2 inconsistency** by either introducing H2 in Section 5 (alongside H1, H3, H4) or removing the reference in the Discussion.

5. **Reframe the explainability section** as a qualitative exploration/illustration rather than an evaluation, and add a sentence clarifying how the logistic regression weights are obtained from each model's features.

## Score and Decision

The paper undertakes an ambitious and practically useful benchmark with genuine strengths in scope, model coverage, and experimental design. However, the missing variance estimates on the central task-fMRI results, the unacknowledged confound between input type and architecture in the biological interpretations, and the overclaiming on disease datasets with non-significant differences collectively prevent the paper from providing the "well-founded empirical guideline" it promises. With substantial revisions — particularly adding error bars, acknowledging limitations, and toning down unsupported claims — the paper could become a valuable contribution.

MY FINAL SCORE: <pineapple>5.5</pineapple>
MY FINAL DECISION: <orange>Reject</orange>